Breaking News, Financial News

Financial Report: Allergan

Specialty pharma sales up 5%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Allergan   2Q Revenues: $1.5 billion (+5%) 2Q Earnings: $296.4 million (+19%) YTD Revenues: $2.9 billion (+7%) YTD Earnings: $526.7 million (+29%) Comments: Specialty pharmaceutical sales were up 5% to $1.2 billion in the quarter. Botox sales were $461.2 million (+10%). Restasis sales were $196.0 million (+13%). Latisse sales were $26.0 million (+19%). Medical device sales were up 4% to $254.8 million....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters